Inflammation in the development of lung cancer: epidemiological evidence

References

• Coussens LM, Werb Z. Inflammation and cancer. Nature420, 860–867 (2002).
   PubMed Web of Science ®Google Scholar
• Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin. Lung Cancer5, 46–62 (2003).
   PubMedGoogle Scholar
• Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J. Clin. Invest.117, 530–538 (2007).
   PubMed Web of Science ®Google Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest.117, 1175–1183 (2007).
   PubMed Web of Science ®Google Scholar
• Peek RM Jr, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a National Cancer Institute-sponsored meeting. Cancer Res.65, 8583–8586 (2005).
   PubMedGoogle Scholar
• Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood76, 655–663 (1990).
   PubMed Web of Science ®Google Scholar
• Bauer AK, Dwyer-Nield LD, Keil K, Koski K, Malkinson AM. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp. Lung Res.27, 197–216 (2001).
   PubMed Web of Science ®Google Scholar
• Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lung remodeling in pulmonary tuberculosis. J. Infect. Dis.192, 1201–1209 (2005).
   PubMed Web of Science ®Google Scholar
• Zheng W, Blot WJ, Liao ML et al. Lung cancer and prior tuberculosis infection in Shanghai. Br. J. Cancer56, 501–504 (1987).
   PubMed Web of Science ®Google Scholar
• Wu-Williams AH, Dai XD, Blot W et al. Lung cancer among women in north-east China. Br. J. Cancer62, 982–987 (1990).
   PubMed Web of Science ®Google Scholar
• Alavanja MC, Brownson RC, Boice JD Jr, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am. J. Epidemiol.136, 623–632 (1992).
   PubMed Web of Science ®Google Scholar
• Wu AH, Fontham ET, Reynolds P et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol.141, 1023–1032 (1995).
   PubMed Web of Science ®Google Scholar
• Brownson RC, Alavanja MC. Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control11, 853–858 (2000).
   PubMed Web of Science ®Google Scholar
• Brenner AV, Wang Z, Kleinerman RA et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int. J. Epidemiol.30, 118–124 (2001).
   PubMed Web of Science ®Google Scholar
• Schabath MB, Delclos GL, Martynowicz MM et al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am. J. Epidemiol.161, 412–422 (2005).
   PubMedGoogle Scholar
• Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol. Biomarkers Prev.14, 773–778 (2005).
   PubMedGoogle Scholar
• Laurila AL, Anttila T, Laara E et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int. J. Cancer74, 31–34 (1997).
   PubMed Web of Science ®Google Scholar
• Renauld JC. New insights into the role of cytokines in asthma. J. Clin. Pathol.54, 577–589 (2001).
   PubMed Web of Science ®Google Scholar
• Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control14, 327–334 (2003).
   PubMed Web of Science ®Google Scholar
• Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc.3, 535–537 (2006).
   PubMedGoogle Scholar
• Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med.101, 2534–2540 (2007).
   PubMed Web of Science ®Google Scholar
• Khalil N, O’Connor R. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ171, 153–160 (2004).
   PubMed Web of Science ®Google Scholar
• Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur. Respir. J.12, 906–912 (1998).
   PubMed Web of Science ®Google Scholar
• Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am. J. Respir. Crit. Care Med.160, 1668–1672 (1999).
   PubMed Web of Science ®Google Scholar
• Il’yasova D, Colbert LH, Harris TB et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol. Biomarkers Prev.14, 2413–2418 (2005).
   PubMed Web of Science ®Google Scholar
• Siemes C, Visser LE, Coebergh JW et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol.24, 5216–5222 (2006).
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF, McWilliams A, Lam S. Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer. Am. J. Respir. Crit. Care Med.173, 535–539 (2006).
   PubMedGoogle Scholar
• Khuder SA, Herial NA, Mutgi AB, Federman DJ. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest127, 748–754 (2005).
   PubMedGoogle Scholar
• Engels EA, Pfeiffer RM, Goedert JJ et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS20, 1645–1654 (2006).
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet370, 59–67 (2007).
   PubMed Web of Science ®Google Scholar
• Bower M, Powles T, Nelson M et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS17, 371–375 (2003).
   PubMed Web of Science ®Google Scholar
• Dal Maso L, Polesel J, Serraino D, Franceschi S. Lung cancer in persons with AIDS in Italy, 1985–1998. AIDS17, 2117–2119 (2003).
   PubMedGoogle Scholar
• Gritz ER, Vidrine DJ, Lazev AB, Amick BC III, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob. Res.6, 71–77 (2004).
   PubMed Web of Science ®Google Scholar
• Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob. Res.7, 511–522 (2005).
   PubMed Web of Science ®Google Scholar
• Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J. Clin. Oncol.24, 1383–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Kirk GD, Merlo C, O’Driscoll P et al. HIV infection is associated with an increased risk for lung cancer independent of smoking. J. Infect. Dis.45, 103–110 (2007).
   Google Scholar
• Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS21, 207–213 (2007).
   PubMed Web of Science ®Google Scholar
• Agostini C, Sancetta R, Cerutti A, Semenzato G. Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J. Leukoc. Biol.58, 495–500 (1995).
   PubMedGoogle Scholar
• Diaz PT, King MA, Pacht ER et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann. Intern. Med.132, 369–372 (2000).
   PubMed Web of Science ®Google Scholar
• Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am. J. Clin. Nutr.67, 143–147 (1998).
   PubMedGoogle Scholar
• Buhl R, Jaffe HA, Holroyd KJ et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet2, 1294–1297 (1989).
   PubMed Web of Science ®Google Scholar
• Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. Polymorphisms of the interleukin-1β gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer109, 353–356 (2004).
   PubMed Web of Science ®Google Scholar
• Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A, Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis25, 229–235 (2004).
   PubMed Web of Science ®Google Scholar
• Campa D, Hung RJ, Mates D et al. Lack of association between polymorphisms in inflammatory genes and lung cancer risk. Cancer Epidemiol. Biomarkers Prev.14, 538–539 (2005).
   PubMed Web of Science ®Google Scholar
• Campa D, Hung RJ, Mates D et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev.14, 2457–2458 (2005).
   PubMed Web of Science ®Google Scholar
• Shih CM, Lee YL, Chiou HL et al. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer50, 291–297 (2005).
   PubMed Web of Science ®Google Scholar
• Shih CM, Lee YL, Chiou HL et al. Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer52, 15–20 (2006).
   PubMed Web of Science ®Google Scholar
• Lee KM, Shen M, Chapman RS et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis28, 1437–1441 (2007).
   PubMed Web of Science ®Google Scholar
• Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res.67, 6520–6527 (2007).
   PubMedGoogle Scholar
• Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst.96, 434–442 (2004).
   PubMed Web of Science ®Google Scholar
• Apte RN, Voronov E. Interleukin-1 – a major pleiotropic cytokine in tumor-host interactions. Semin. Cancer Biol.12, 277–290 (2002).
   PubMed Web of Science ®Google Scholar
• Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur. J. Clin. Invest.22, 396–402 (1992).
   PubMed Web of Science ®Google Scholar
• Latkovskis G, Licis N, Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur. J. Immunogenet.31, 207–213 (2004).
   PubMedGoogle Scholar
• Berger P, McConnell JP, Nunn M et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine.17, 171–174 (2002).
   PubMed Web of Science ®Google Scholar
• Eklund C, Lehtimaki T, Hurme M. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int. J. Immunogenet.32, 229–232 (2005).
   PubMedGoogle Scholar